Please assess the completion status of the following clinical trial:

Trial Title: Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male patients aged 50 years or older~* a medical claim of EP~* a prescription claim for a 5ARI and AB (provided both are within 180 days of index date)~* continuously eligible for 6 months prior to and at least 12 months after index prescription date.~Exclusion Criteria:~* diagnosis of prostate or bladder cancer~* any prostate-related surgical procedure within 5 months of index date~* prescription claim for finasteride indicative of male pattern baldness~* 5ARI therapy initiated prior to initiating AB therapy

- Gender: MALE
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Early 5ARI Initiation (Type: None): Patients with EP receiving combination therapy (AB + 5ARI) with early initiation of 5ARI (within 30 days of initiation of AB)
- Late 5ARI Initiation (Type: None): Patients with EP receiving combination therapy (AB + 5ARI) with late initiation of 5ARI (more than 30 days but less than 6 months after initiation of AB)

Based on this trial design, predict the completion outcome and termination type (if applicable).